Sustained Virological Response in Special Populations with Chronic Hepatitis C Using Interferon-Free Treatments: A Systematic Review and Meta-analysis of Observational Cohort Studies.

Vinicius Lins FerreiraLetícia Paula LeonartFernanda Stumpf ToninHelena Hiemisch Lobo BorbaRoberto Pontarolo

Published in: Clinical drug investigation (2018)

In order to choose the best treatment option, it is necessary to consider the patients' conditions and characteristics. In conclusion, the use of IFN-free therapies meets the high expectations created by clinical trials, including patients in special clinical conditions.

Keyphrases

end stage renal disease
clinical trial
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
randomized controlled trial
patient reported outcomes
study protocol
patient reported
phase ii
replacement therapy